Press Release
Press Release
Innate to advance lacutamab towards TELLOMAK-3 Phase 3 following the partnership with Sobi, a key step toward the
Read Full Story
Press Release
Press Release
Press Release
Press Release
Press Release
Press Release
Press Release
Press Release
Press Release
Press Release
Press Release